Endometrial disease
Conditions
Interventions
group 1:remazolam 0mg/kg
group 2:remazolam 0.1mg/kg
group 3:remazolam 0.15mg/kg
group 4:remazolam 0.2mg/kg
group 5:remazolam 0.25mg/kg
group 6:remazolam 0.3mg/kg
Sponsors
Women's Hospital, Zhejiang University School of Medicine
Eligibility
Sex/Gender
Female
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1. Patients undergoing hysteroscopic surgery under intravenous anesthesia, ASA grade I-II, aged 20-50 years, BMI 18-24. 2. No electrolyte disorders, diseases of infection, immune system or endocrine system; no cardiovascular drugs, non-steroidal anti-inflammatory drugs, hormone drugs or antipsychotic drugs taken recently.
Exclusion criteria
Exclusion criteria: 1. Previous history of vaginal delivery; 2. Patients with abnormal liver and kidney function; 3. History of cardiopulmonary disease; 4. Sleep apnea syndrome; 5. Long-term use of drugs such as diazepam; 6. Chronic use of opioids; 7. Remazolam allergy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Half effective concentration of propofol; | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative vital signs;The recovery time; | — |
Countries
China
Contacts
Public ContactChen Xinzhong
Outcome results
None listed